Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2
Recruiting1
Terminated1

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT06478017Phase 2Recruiting
Belatacept in Heart Transplantation
Heart Transplant
StudychairStart date: 2025-01-29
NCT00788021Completed
Protective Immunity Project 01
ImmunityImmunosuppressionKidney Transplantation
Principalinvestigator
NCT00833651Completed
Protective Immunity Project 02
ImmunologyImmunosuppressionKidney Transplant
Principalinvestigator
NCT01436305Phase 2Terminated
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Kidney TransplantationRenal Transplantation
Principalinvestigator

Research Network

Collaboration Network

10 collaborators·12 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kenneth E Kokko, MD, PhD

Emory University

Moderately Similar
1 trials

Shared therapeutic areas:

ImmunologyImmunosuppression TherapyKidney Transplant

Worked with same sponsors:

Emory University
Collaborated on 1 trial
Similarity Score34%

Kenneth E. Kokko, MD, PhD

Emory University

Moderately Similar
1 trials

Shared therapeutic areas:

ImmunityImmunosuppression TherapyKidney Transplantation

Worked with same sponsors:

Emory University
Collaborated on 1 trial
Similarity Score34%

Marlena Habal, MD

NYU Langone Health

Related
1 trials

Shared therapeutic areas:

Heart Transplant

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Jon A. Kobashigawa, MD

Cedars-Sinai Medical Center

Related
1 trials

Shared therapeutic areas:

Heart Transplant

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Joren C Madsen, MD, DPhil

Massachusetts General Hospital

Related
1 trials

Shared therapeutic areas:

Heart Transplant

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Kenneth Newell, MD, PhD

Emory University

Related
5 trials

Shared therapeutic areas:

Kidney Transplantation

Worked with same sponsors:

Clinical Trials in Organ TransplantationNational Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Peter S. Heeger, MD

Icahn School of Medicine at Mount Sinai

Related
4 trials

Shared therapeutic areas:

Heart TransplantKidney Transplantation

Worked with same sponsors:

Clinical Trials in Organ TransplantationNational Institute of Allergy and Infectious Diseases (NIAID)
Similarity Score10%

Mark D. Stegall, M.D.

Mayo Clinic

Related
6 trials

Shared therapeutic areas:

Kidney TransplantKidney Transplantation
Similarity Score10%

Raymond Vanholder, MD, PhD

University Hospital, Ghent

Related
12 trials

Shared therapeutic areas:

Kidney Transplantation
Similarity Score5%

A. John Barrett, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
7 trials

Shared therapeutic areas:

Immunosuppression Therapy
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06478017Phase 2StudyChair

Belatacept in Heart Transplantation

Heart Transplant
Recruiting
NCT00788021PrincipalInvestigator

Protective Immunity Project 01

ImmunityImmunosuppressionKidney Transplantation
Completed
NCT00833651PrincipalInvestigator

Protective Immunity Project 02

ImmunologyImmunosuppressionKidney Transplant
Completed
NCT01436305Phase 2PrincipalInvestigator

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

Kidney TransplantationRenal Transplantation
Terminated

All 4 trials loaded